|

Continuous Glucose Monitoring (CGM) After Kidney Transplantation

RECRUITINGSponsored by Bo Feldt-Rasmussen
Actively Recruiting
SponsorBo Feldt-Rasmussen
Started2024-11-12
Est. completion2026-01-01
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06675903

Summary

This study examines glucose levels measured by continuous glucose monitoring (CGM) in the immediate period following kidney transplantation among recipients with diabetes, without diabetes, and with pre-diabetes. The primary objective is to analyse differences in mean sensor glucose between these three groups. CGMs are applied to participants within 72 hours after kidney transplantation, with a total of 54 participants divided equally across the three groups (18 in each). Secondary objectives include assessing additional glucose profile indices, adherence to relevant guidelines, changes in HbA1c, the impact of immunosuppression and steroid dosage, and beta cell function.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Written informed consent obtained before CGM application
* Male or female; age: ≥18 years
* Kidney transplantation

Exclusion Criteria:

* Unable to cooperate to CGM the first ten days after surgery
* Allergic to plasters in CGM units
* Combined kidney and liver or pancreatic transplantation
* Graft loss/rejection within first 48 hours after transplantation

Conditions3

DiabetesHyperglycaemiaKidney Transplantation

Browse More Trials

Diabetes trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.